Define a signature of gut microbiota composition and related metabolites in patients with ST-elevation myocardial infarction, non ST-elevation myocardial infarction and chronic coronary disease (CAD).
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Microbiota alpha diversity in myocardial infarction measured as Chao1 Index.
Timeframe: Within 7 days from inclusion.
Microbiota alpha diversity in myocardial infarction measured as Chao1 Index
Timeframe: At 3 months follow-up.
Lipopolysaccharide binding protein (LBP) in myocardial infarction
Timeframe: At inclusion
Lipopolysaccharide binding protein (LBP) in myocardial infarction
Timeframe: Change from inclusion to 3 months follow-up.
Soluble cluster of difference-14 in myocardial infarction
Timeframe: At inclusion
Soluble cluster of difference-14 in myocardial infarction
Timeframe: Change from inclusion to 3 months follow-up.
Intestinal fatty acid binding protein-1 in myocardial infarction
Timeframe: At inclusion
Intestinal fatty acid binding protein-1 in myocardial infarction
Timeframe: Change from inclusion to 3 months follow-up.